Mark Wesker
![Mark Wesker](https://oc-static.poweredbyproctors.co.uk/public/lawyer_images/mark.wesker.png?VersionId=Dw8GHNa.rQWFciO71km6sZPKqBv15t57)
Mark is a Partner in Osborne Clarke's corporate team and Financial Services sector teams.
Mark is a highly experienced corporate lawyer, regularly advising on a broad range of matters including business strategy, M&A, takeovers, IPOs, fundraising, joint ventures, restructuring and corporate governance. The matters Mark advises on are frequently strategically important and/or complex, often cross-border.
Mark's clients range from large institutions and listed businesses through to funds/investors, scale-ups and successful entrepreneurs.
Mark has broad experience across a number of industry sectors but has particular experience and focus in the Financial Services and FinTech sectors, as well as TMT / Tech, Media and Comms.
Mark has been at Osborne Clarke since 2008. Prior to that he worked at Slaughter and May in London, with a period working in New York.
Sale of a 25% stake in the UK's leading independent mortgage broker, London & Country Mortgages (L&C), to Experian plc.
Rectification of unlawful dividends paid by FTSE100 UK leading investment platform Hargreaves Lansdown plc.
£158m AIM IPO of FeverTree Drinks plc.
Acquisition by Computershare of international share schemes business Equatex from private equity firm Montagu.
£60m rescue rights issue and disposal of Synergy business for software business Tribal Group plc.
£50m acquisition by PTC of software business Atego Systems Limited
£85m retail bond issue for The UNITE Group plc.
Advised on FTSE-250 listed company UNITE's debut retail bond issue.
Advised on their debut retail bond issue
Advised on its £7m takeover of AIM listed Datong, leading provider of intelligence equipment and solutions, creating one of the sectors largest independent specialist technology engineering businesses
Advised Clydesdale Bank Corporate & Structured Finance on its funding of a merger between two leading speciality pharmaceutical companies. The bank has agreed a £16m senior funding package to support IS Pharma plc and Sinclair Pharma plc, which are planning to join forces to create Sinclair IS Pharma plc, a substantial, fully integrated pan-European speciality pharmaceutical business
Advised on its formation and the arrangements between it and its co-sponsors.
Advised on its $50m acquisition of Atego, a developer of model-based systems and software engineering applications
Advised Actual Experience plc on £16m share placing from new and existing shareholders
Advised Empresaria, an international specialist staffing group, on the £3.3m accelerated bookbuild used to part finance the acquisition of US healthcare recruiter PS.
Welcome to the latest edition of Osborne Clarke's Quoted Company Update.
Wide sweeping reforms have been proposed by the UK Listings Review , chaired by Lord Jonathan Hill, as part of...
Following the adoption of virtual and hybrid meetings during the global pandemic, the GC100 has released a discussion paper around...
As the end of the UK's transition period with the EU fast approaches, listed companies should make sure they are...
Now is the time for businesses to consider the options available to them to recapitalise their businesses, through debt or...
The government has published its Corporate Insolvency and Governance Bill, which contains important measures for companies that need to hold...
March to May in any year is typically the period during which listed companies with financial years ending on 31...